Hepatitis C Virus (HCV): Basic Building Blocks for the Healthcare Professional

This program is no longer accredited for nurses. 

TITLE - Hepatitis C Virus (HCV): Basic Building Blocks for the Healthcare Professional

TARGET AUDIENCE - Target audiences for this program are Specialty Pharmacists, Pharmacists, Clinical Pharmacists, Specialty Pharmacy executives, Pharmacy Directors, Chief Pharmacy Officers, Infectious Disease Pharmacists, Infectious Disease Nurses and Nurses

LEARNING OBJECTIVES - After completing the program, Specialty Pharmacists, Pharmacists, Clinical Pharmacists, Specialty Pharmacy executives, Pharmacy Directors, Chief Pharmacy Officers, Infectious Disease Pharmacists, Infectious Disease Nurses and Nurses, along with other healthcare practitioner participants will be able to:

  1. Describe the pathophysiology and etiology of hepatitis C virus (HCV)
  2. Discuss the global burden and epidemiology of HCV
  3. List the various HCV genotypes
  4. List the risk factors for HCV transmission
  5. Explain the progression and staging of HCV
  6. Identify extrahepatic manifestations of HCV
  7. Describe updated guidelines on screening and diagnosis of HCV
  8. Discuss strategies for open communication with patients, family members, specialists and other members of the healthcare team

Faculty Disclosures:

Before the activity, all faculty and anyone who is in a position to have control over the content of this activity and their spouse/life partner will disclose the existence of any financial interest and/or relationship(s) they might have with any commercial interest producing healthcare goods/ services to be discussed during their presentation(s): honoraria, expenses, grants, consulting roles, speakers bureau membership, stock ownership, or other special relationships. Presenters will inform participants of any off-label discussions. All identified conflicts of interest are thoroughly vetted by the Specialty Pharma Education Center for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

Faculty Disclosure: Michelle T. Martin, PharmD, FCCP, BCPS, BCACP, is a minor shareholder for AbbVie, Gilead, and Merck and has served on an advisory board for Gilead. She intends to discuss non-FDA approved drugs or investigational use of HCV medications per the HCV guidelines. 

Pharmacist continuing education credit

Specialty Pharma Education Center (SPEC) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This program is approved for 2.0 hours (0.20CEUs) of continuing pharmacy education credit. Proof of participation will be posted to your NABP CPE profile within 4 to 6 weeks to participants who have successfully completed the post-test (score of 70% or higher). Participants will have 3 opportunities to pass the post-test. Participants must participate in the entire presentation and complete the course evaluation to receive continuing pharmacy education credit.
ACPE #0535-0000-17-040-H01-P

Knowledge Based Activity

Course release date 10/12/2017

Course expires 10/12/2020

Nursing continuing education credit

Educational Review Systems is an approved provider of continuing nursing education by the Alabama State Nursing Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.  Provider # 5-115.  This program is approved for 2 hours of continuing nursing education.

Educational Review Systems is also approved for nursing continuing education by the state of California, the state of Florida and the District of Columbia.

Course release date 11/27/2017

Course expires 11/27/2019

Credit Information

Activity Number Credit Amount Accreditation Period
0535-0000-17-040-H01-P 0.2 CEUs October 12, 2017 - October 12, 2020